Overnight Health Care – White House Praises Vaccine Tariff For Feds

Welcome to Monday’s Nighttime Health Care, where we follow the latest developments in health policies and news. Register here: thehill.com/newsletter-subscription.

It’s starting to look a lot like Christmas at the White House — even before Thanksgiving — when Jill BidenJill BidenBiden speaks on economics Tuesday, with Fed pick upcoming Biden, top officials dispersed to promote Ciara infrastructure package to promote childhood vaccinations alongside Jill Biden MORE welcomed the White House tree for the first time as first lady.

More than 90 percent of federal workers will be vaccinated against COVID-19 before today’s deadline, according to the White House.

For The Hill we are Peter Sullivan (psullivan@thehill.com), Nathaniel Weixel (nweixel@thehill.com) and Justine Coleman (jcoleman@thehill.com). Write us with tips and feedback and follow us on Twitter: @PeterSullivan4, @NateWeixel and @ JustineColeman8.

Let’s start.

Most federal workers vaccinated by deadline

More than 90 percent of the federal workforce has received at least one shot of a COVID-19 vaccine, the White House said Monday, the deadline for President BidenJoe BidenBiden speaks on economics Tuesday with NAACP president-elect, calls Rittenhouse ruling ‘a warning shot that vigilante justice is allowed’ Democrats optimistic as social spending bill goes to Senate MOREfederal employee mandate.

Another about 5 percent comply with the rules by having a valid exception or an extension request, a senior official said, bringing the total to 95 percent.

For the small percentage of employees who fail to comply, which still translates into thousands of people out of more than 3.5 million federal employees, “agencies begin a training and advisory process, followed by additional enforcement action as needed,” it says. the official said.

Wider Pressure: The Biden administration hopes high adoption among federal workers sets an example for private sector employers as part of increased push for vaccine mandate. The administration’s vaccination or testing requirement for companies with 100 or more employees is scheduled to take effect Jan. 4, although it is currently being interrupted by a federal appeals court.

“As progress in the federal government has shown, these requirements are working — and we hope our implementation can serve as an example for other companies of all sizes to move forward with similar measures that protect their workforce, protect their customers, and our communities.” said the senior government official.

Read more here.

Fauci: Don’t ‘premature’ end-mask mandates

Top expert infectious diseases Anthony FaucicAnthony FauciSunday shows – Spotlight shifts to Senate for spending plan Biden Fauci says fully vaccinated families can ‘definitely’ enjoy vacations indoors without masks COVID-19 cases increase with Thanksgiving gatherings en route MORE warned on Monday against the “premature” dropping of mask mandates as Washington, DC, despite opposition from city council members, lifts the requirement for indoor masks.

President Biden’s chief medical adviser said: NPR’s “Morning Edition” that the city’s move “adds an extra degree of risk” as the country sees increasing cases and hospitalizations as it enters the holiday season.

“When you have that kind of dynamic … you have to be really careful,” he said. “Masks won’t last forever. The more people get vaccinated, the more people get a boost, the lower the infection level in the community will be, and then you start to think about pulling masks back.

“But you don’t want to do it prematurely,” he added. “As much as you’d like to do it, you have to be careful.”

Fauci pointed to the national increase in the number of cases, citing that they are up 29 percent from two weeks earlier. Hospital admissions are up 6 percent while deaths continue to decline, though he warned that fatalities are “usually a lagging indicator.”

What’s next: When asked when mask mandates may end, Fauci said it’s “hard to predict” but he hopes it will be “as we get through the winter and head into spring.”

“But you can’t guarantee it,” he added. “This virus has fooled us before. It’s a very cunning virus – this delta variant.

Read more here.

GROUPS PRESS BIDEN ABOUT INTELLECTUAL PROPERTY DISTANCE FOR COVID-19 VACCINE

More than a dozen medical and human rights groups have joined forces to call on President Biden to take action in support of an intellectual property waiver for COVID-19 vaccines, in an effort to pressure the government into trying to control the global economy. improve access to shots.

The 15 organizations, including Doctors Without Borders, Human Rights Watch and Public Citizen, sent a letter to the White House on Friday requesting Biden’s “personal involvement” in the matter. The groups are pushing for a temporary waiver at the World Trade Organization (WTO) to boost production and stockpiles for COVID-19 vaccines, treatments and tests.

The groups said they are “deeply disappointed” with the Biden administration for its lack of action, beyond the president’s approval in May, “as millions die or become seriously ill while waiting for effective vaccines and treatments.”

The administration has previously declared his support for an intellectual property exemption for the COVID-19 vaccines in May. The White House also last month called on all WTO members to support an intellectual property exemption for the vaccines.

But the organizations said in the letter that “no progress has been made in implementing it.”

The groups called for action on this waiver at the upcoming WTO ministerial conference scheduled for the end of this month.

Read more here.

House seeks interview with former FDA leader

House subcommittee examining US response to coronavirus wants to ask questions Stephen HahnStephen HahnTrump discussed sending infected Americans to Guantanamo Bay: Book Stephen Hahn joins venture capital firm behind Moderna Redfield says Azar pressured him to review COVID-19 data reports MORE, earlier President TrumpDonald Trump Two Fox News Contributors Quit Over Tucker Carlson’s Documentary GOP Senator Jan. 6: Bills Decisions Not Made Based On Whether They Hurt Or Help Trump Or Biden O’Rourke Won’t Say Whether He Wants that Biden is campaigning for him in Texas Senate race MORE‘s Food and Drug Administration Commissioner, on attempts to improperly interfere with the agency’s assessment of COVID-19 therapies and vaccines, and to promote drugs with minimal benefit.

The committee sent a letter to Hahn on Monday requesting that he be present for an interview on December 16 and provide documents and communications by December 6.

The FDA faced an onslaught from political appointees across the administration to accelerate approval of therapies and vaccines that would demonstrate the Trump administration’s control of the pandemic, including hydroxychloroquine and restorative plasma.

“Given the ongoing campaigns to promote the use of questionable coronavirus treatments, the Select Subcommittee is seeking to understand the full scope and impact of Trump Administration officials’ efforts to influence these FDA decisions,” panel chair Rep. James Clyburn (DS.C.) wrote.

Looking for answers: The commission wants information about Trump officials’ efforts to promote the use of chloroquine and hydroxychloroquine, antimalarial drugs that Trump touted as a panacea despite there being no evidence.

The agency granted emergency use approval for hydroxychloroquine in late March 2020. The panel cited reports between Hahn and other agency officials expressing concerns that hydroxychloroquine was ineffective and potentially dangerous; the FDA only formally revoked the license in June.

The panel also wants to know more about the authorization of restorative plasma. The FDA rushed to issue an emergency plasma permit on August 23, 2020, after Trump pressured the agency to act more quickly in crowding out coronavirus treatments and vaccines, despite scientists saying more research was needed.

Read more here.

AMA WARNS OF SERIOUS, IRREVERSIBLE DAMAGE IF Vaccine Mandate IS DISCONTINUED

The American Medical Association (AMA) warned that stopping the Biden administration’s coronavirus vaccine or testing requirements for private companies “would seriously and irreparably harm the public interest.”

In a filing with the United States Court of Appeals for the 5th Circuit, the AMA said COVID-19 poses a “serious danger to the public” that “wreaks havoc on communities across the country.” The association said it has filed a briefing on the friend of the court because it has “an interest in providing evidence-based guidance on public health issues”.

The 5th Circuit has since placed a nationwide pause in the order, but now all lawsuits have been condensed into the 6th Circuit, which has yet to rule on any motions.

In particular, the doctors’ association noted that the transmission of COVID-19 in the workplace was a large part of the spread of the virus in several industries.

“The more workers are vaccinated, the closer we get to slowing the spread of the virus and creating a safer environment,” the AMA said.

The filing also called vaccine requirements a “critical” part of ending the pandemic, citing past vaccine mandates for diseases such as measles and smallpox.

Read more here.

WHAT WE READ

  • Stubborn Covid waves signal gloomy winter (Politics)
  • Medical Debt Is Crushing Black Americans, And Hospitals Are Not Helping (Bloomberg News)
  • Concerns grow over the safety of Aduhelm after the death of the patient who received the drug (New York Times)
  • Why You Can’t Find Cheap Home Covid Tests (Kaiser Health News)

STATE FOR STATE

That’s it for today, thanks for reading. Check out The Hill’s healthcare page for the latest news and coverage. See you on Tuesday.

.

Leave a Comment